Article Text

PDF
F2 Longitudinal evaluation of the registry cognitive battery across the different stages of huntington’s disease
  1. Verena Baake1,2,
  2. Robert HAM Reijntjes1,
  3. Eve M Dumas3,
  4. Jennifer Thompson4,5,
  5. Raymund AC Roos1
  1. 1Leiden University Medical Centre, Department of Neurology, RC Leiden, The Netherlands
  2. 2Topaz, Leiden, The Netherlands
  3. 3Tjongerschans hospital, Heerenveen, The Netherlands
  4. 4Manchester Academic Health Sciences Centre, Greater Manchester Neuroscience Centre, Salford Royal NHS Foundation Trust and Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK
  5. 5Membership of the REGISTRY Investigators of the European Huntington’s Disease Network is provided in the acknowledgments

Abstract

Background In Huntington’s disease (HD) cognitive decline can occur before unequivocal motor signs become apparent. Unfortunately, the exact progression of cognitive decline is unknown. As cognitive decline starts early in the course of the disease and shows a progressive nature cognition can be seen as a key target for symptomatic treatment.

Objective The main aim of this study is to evaluate the progression of cognitive decline across all HD stages, from pre-motormanifest to advanced HD.

Methods In the European REGISTRY study 2669 HD expansion gene carriers underwent annual cognitive assessment. General linear mixed models were used to model the cognitive decline for each cognitive task across all disease stages. Additionally, a model was established to evaluate the cognitive decline based on CAG length and age rather than disease stage.

Results All administered tasks are sensitive in discriminating between pre-motormanifest (close to estimated disease onset) and the subsequent motormanifest stages from 1 till stage 4. The first two cards of the Stroop discriminate from pre-motormanifest (far from estimated disease onset) through the latest stage 5.

The model with CAG length and age revealed that CAG length gives the best indication about the cognitive performance and the performance declines with older age.

Conclusion The in REGISTRY administered cognitive tasks are sensitive to discriminate between all stages of the disease. It seems that cognitive performance is the most dependent on CAG length and performance worsens over time.

  • cognition
  • longitudinal

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.